Table 1.

Summary of studies using iron oxide nanoparticles for brain tumor applications.

Application	Type of study	References
Imaging
MRI (Negative contrast)	preclinical model	[64,192–195,203–204,206–209,209–210,213,102–103,105,126,174]
MRI (Positive contrast)	preclinical model	[202,205]
MRI	clinical, human patients	[211,212]
MPI	preclinical model	[214]
Targeting
Magnetic targeting	preclinical model	[8,196–199,203–204,93,102,89]
Treatment
Delivery of therapeutic molecules	preclinical model	[199–200,206,209–210]
Magnetic hyperthermia	preclinical model	[201]
Magnetic hyperthermia	clinical, human patients	[215]
Cell based	preclinical model	[209,208,216]